Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21844082 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: n-3 PUFAs;   Drug: Placebo;   Drug: RASS inhibitors and/or RAS blockers;   Drug: Amiodarone

Indicates status has not been verified in more than two years